HALO vs PHM · P/E 15, rev $857.7M vs P/E 7.7, rev $7.39B
Halozyme Therapeutics Inc (HALO) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the HALO and PHM stock pages for the full models.
Not investment advice.